Improving Adjuvant Endocrine Treatment Tailoring in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

被引：30
作者：
Lambertini, Matteo [1 ,2 ]
Blondeaux, Eva [1 ]
Perrone, Francesco [3 ]
Del Mastro, Lucia [1 ,2 ]
机构：
[1] IRCCS Osped Policlin San Martino, Genoa, Italy
[2] Univ Genoa, Genoa, Italy
[3] IRCCS Fdn G Pascale, Ist Nazl Tumori, Naples, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 12期
关键词：
OVARIAN-FUNCTION SUPPRESSION; INTERNATIONAL CONSENSUS GUIDELINES; PATIENT-REPORTED OUTCOMES; PLUS ZOLEDRONIC ACID; QUALITY-OF-LIFE; CLINICAL-PRACTICE; YOUNG-WOMEN; ITALIAN ASSOCIATION; FERTILITY CONCERNS; AMERICAN SOCIETY;
D O I：
10.1200/JCO.19.02242
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice.
引用
收藏
页码：1258 / +
页数：11
相关论文
共 70 条
  • [1] [Anonymous], J CLIN ONCOL
  • [2] Genomic aberrations in young and elderly breast cancer patients
    Azim, Hatem A., Jr.
    Nguyen, Bastien
    Brohee, Sylvain
    Zoppoli, Gabriele
    Sotiriou, Christos
    [J]. BMC MEDICINE, 2015, 13
  • [3] Biology of breast cancer in young women
    Azim, Hatem A., Jr.
    Partridge, Ann H.
    [J]. BREAST CANCER RESEARCH, 2014, 16 (04):
  • [4] HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2
    Bartlett, John M. S.
    Ahmed, Ikhlaaq
    Regan, Meredith M.
    Sestak, Ivana
    Mallon, Elizabeth A.
    Dell'Orto, Patrizia
    Thurlimann, Beat
    Seynaeve, Caroline
    Putter, Hein
    Van de Velde, Cornelis J. H.
    Brookes, Cassandra L.
    Forbes, John F.
    Viale, Giuseppe
    Cuzick, Jack
    Dowsett, Mitchell
    Rea, Daniel W.
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 79 : 129 - 138
  • [5] Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy
    Bellet, Meritxell
    Gray, Kathryn P.
    Francis, Prudence A.
    Lang, Istvan
    Ciruelos, Eva
    Lluch, Ana
    Angel Climent, Miguel
    Catalan, Gustavo
    Avella, Antoni
    Bohn, Uriel
    Gonzalez-Martin, Antonio
    Ferrer, Roser
    Catalan, Roberto
    Azaro, Analia
    Rajasekaran, Agnita
    Morales, Josefa
    Vazquez, Josep
    Fleming, Gini F.
    Price, Karen N.
    Regan, Meredith M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (14) : 1584 - U89
  • [6] Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials
    Bernhard, Juerg
    Luo, Weixiu
    Ribi, Karin
    Colleoni, Marco
    Burstein, Harold J.
    Tondini, Carlo
    Pinotti, Graziella
    Spazzapan, Simon
    Ruhstaller, Thomas
    Puglisi, Fabio
    Pavesi, Lorenzo
    Parmar, Vani
    Regan, Meredith M.
    Pagani, Olivia
    Fleming, Gini F.
    Francis, Prudence A.
    Price, Karen N.
    Coates, Alan S.
    Gelber, Richard D.
    Goldhirsch, Aron
    Walley, Barbara A.
    [J]. LANCET ONCOLOGY, 2015, 16 (07) : 848 - 858
  • [7] Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019
    Burstein, H. J.
    Curigliano, G.
    Loibl, S.
    Dubsky, P.
    Gnant, M.
    Poortmans, P.
    Colleoni, M.
    Denkert, C.
    Piccart-Gebhart, M.
    Regan, M.
    Senn, H. -J.
    Winer, E. P.
    Thurlimann, B.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 (10) : 1541 - 1557
  • [8] Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update
    Burstein, Harold J.
    Lacchetti, Christina
    Anderson, Holly
    Buchholz, Thomas A.
    Davidson, Nancy E.
    Gelmon, Karen A.
    Giordano, Sharon H.
    Hudis, Clifford A.
    Solky, Alexander J.
    Stearns, Vered
    Winer, Eric P.
    Griggs, Jennifer J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (05) : 423 - +
  • [9] Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression
    Burstein, Harold J.
    Lacchetti, Christina
    Anderson, Holly
    Buchholz, Thomas A.
    Davidson, Nancy E.
    Gelmon, Karen E.
    Giordano, Sharon H.
    Hudis, Clifford A.
    Solky, Alexander J.
    Stearns, Vered
    Winer, Eric P.
    Griggs, Jennifer J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (14) : 1689 - U250
  • [10] Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
    Burstein, Harold J.
    Temin, Sarah
    Anderson, Holly
    Buchholz, Thomas A.
    Davidson, Nancy E.
    Gelmon, Karen E.
    Giordano, Sharon H.
    Hudis, Clifford A.
    Rowden, Diana
    Solky, Alexander J.
    Stearns, Vered
    Winer, Eric P.
    Griggs, Jennifer J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (21) : 2255 - +
1234567